Wacker-Chemie buys ProThera
Wacker-Chemie is to acquire German biotechnology company ProThera, based in Jena, to boost its presence in the biologics manufacturing sector. ProThera will now operate as Wacker Biotech.
Wacker-Chemie is to acquire German biotechnology company ProThera, based in Jena, to boost its presence in the biologics manufacturing sector. ProThera will now operate as Wacker Biotech.
Despite burgeoning demand for biopharmaceutical drugs, little progress is being made toward the improving efficiency and reducing costs in conventional biomanufacturing processes using microbial or mammalian fermentation systems.
Medical device company Boston Scientific has launched a new cardiovascular stent designed to deliver the drug paclitaxel in 18 countries around the world, stealing a march on arch-rival Johnson & Johnson.
Materials testing specialist Stable Micro Systems has launched a texture analysis device which promises to increase productivity and improve cost-effectiveness where higher volume, repetitive quality testing is required.
Croda Healthcare's medical grade lanolin ingredient - used in a number of dermatological brands including the top-selling emollient product in the UK - has outperformed the industry standard emollient, petrolatum, in clinical trials.